Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants.
D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis / Q000097:blood / Q000235:genetics*; D001169:Arthritis, Experimental / Q000139:chemically induced / Q000473:pathology / Q000628:therapy*; D001483:Base Sequence; D003094:Collagen; D019281:Dimerization; D004305:Dose-Response Relationship, Drug; D004563:Electrochemistry; D018274:Electroporation / Q000379:methods*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D007273:Injections, Intramuscular; D051379:Mice; D008969:Molecular Sequence Data; D010957:Plasmids / Q000235:genetics / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor / Q000096:biosynthesis / Q000097:blood / Q000235:genetics*; D047888:Receptors, Tumor Necrosis Factor, Type I; D011993:Recombinant Fusion Proteins / Q000378:metabolism
D015703:Antigens, CD; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D011993:Recombinant Fusion Proteins; D003094:Collagen